Submit your email to push it up the queue
Bayer AG, a global leader in the life sciences sector, is headquartered in Leverkusen, Germany. Founded in 1863, Bayer has established itself as a prominent player in the pharmaceutical, consumer health, and agricultural industries. The company operates extensively across Europe, North America, and Asia, providing innovative solutions that enhance health and nutrition. Bayer's core offerings include prescription medications, over-the-counter products, and crop science solutions, distinguished by their commitment to research and development. Notable achievements include the development of groundbreaking treatments and sustainable agricultural practices, positioning Bayer as a trusted name in health and agriculture. With a strong market presence and a dedication to improving lives, Bayer continues to drive advancements that benefit society globally.
How does Bayer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bayer's score of 74 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Bayer AG reported total greenhouse gas emissions of approximately 11,340,000,000 kg CO2e. This includes Scope 1 emissions of about 1,880,000,000 kg CO2e, Scope 2 emissions of approximately 1,080,000,000 kg CO2e (market-based), and significant Scope 3 emissions totalling around 7,700,000,000 kg CO2e. The company has set ambitious climate commitments, aiming for net-zero emissions across all scopes by 2050. Bayer's near-term targets include a reduction of absolute Scope 1 and 2 emissions by 42% by the end of 2029, relative to a 2019 baseline. Additionally, Bayer aims to reduce Scope 3 emissions by 12% within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Bayer's commitment to sustainable practices in the pharmaceutical and biotechnology sector. In 2023, Bayer's total emissions were reported at approximately 12,200,000,000 kg CO2e, indicating a slight decrease in emissions from the previous year. The company continues to implement energy efficiency measures and transition to renewable energy sources to meet its reduction goals. Bayer's long-term strategy includes achieving climate neutrality at all its sites by 2030, with a focus on reducing emissions through energy efficiency and renewable energy procurement. The company is also committed to enabling its agricultural customers to reduce their greenhouse gas emissions per kilogram of crop produced by 30% by 2030. Overall, Bayer AG is actively working towards significant emissions reductions and has established a comprehensive framework to address climate change within its operations and supply chain.
Access structured emissions data, company-specific emission factors, and source documents
2008 | 2009 | 2010 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 5,090,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Scope 2 | 3,570,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bayer is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.